60
Participants
Start Date
January 1, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
DualStim Therapy
6 DualStim Therapies over a period of 7 weeks.
Umbilical cord-derived Wharton's Jelly
2 intracavernosal injections over a period of 7 weeks.
Saline
2 intracavernosal injections over a period of 7 weeks.
Lead Sponsor
BioIntegrate
INDUSTRY